Skip to Content

BR 522 (Aplenzin 522 mg)

Generic Name: bupropion

Pill imprint BR 522 has been identified as Aplenzin 522 mg.

Aplenzin is used in the treatment of major depressive disorder; depression and belongs to the drug class miscellaneous antidepressants. Risk cannot be ruled out during pregnancy. Aplenzin 522 mg is not a controlled substance under the Controlled Substance Act (CSA).

Aplenzin 522 mg BR 522
Aplenzin 522 mg BR 522
Aplenzin 522 mg BR 522
Aplenzin
Generic Name:
bupropion
Imprint:
BR 522
Strength:
522 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Sanofi-Aventis
National Drug Code (NDC):
00024-5812
Inactive Ingredients:
ethylcellulose (100 mPa.s)
glyceryl behenate
polyvinyl alcohol
polyethylene glycol
povidone
dibutyl sebacate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00187-5812 Valeant Pharmaceuticals International, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide